SlideShare uma empresa Scribd logo
1 de 123
Acute and chronic pain
Management
k/Mariam Tamrat
Pain lecture
 Module Title: Anaesthesia Management III
 Course Title:- ICU and Pain Management
 Course Number:- Anst 5172
 Credit Hours:- 3
 Course Description:- This course is designed to enable the anaesthetist to
effectively assess and manage pain as well as identify, assess and manage
patients who are critically ill.
21/08/09 2
Cont..
 Course Objectives:-
 By the end of the course the student will be able to:
 Define pain & explain the physiology of pain
 Competently assess & manage acute post operative and non post-operative
pain.
 Understand the basics of chronic pain management
21/10/20
09 3
Pain…
What is the real definition of pain?
And what is pain management??
How can this information help me???
18/8/09
4
Group Assignment
 G1. Describe the characteristics and genesis of pain
 G2. Explain the categories of pain
 G3.Manage pain Effectively
 G4.Consequences of untreated pain
Submit after a week.
Definition of Pain
An Unpleasant Sensory and Emotional
Experience Associated with Actual or
Potential Tissue Damage, or Described
in Terms of Such Damage.
Physiology of Pain
INTRODUCTION
 Pain is defined by the International Association for
the Study of Pain (IASP) as ‘an unpleasant sensory
and emotional experience associated with actual
or potential tissue damage or described in terms of
such damage’.
 Pain has objective, physiological sensory aspects
as well as subjective, emotional and psychological
components.
 The term ‘nociception’ is used only to describe the
neural response to traumatic or noxious stimuli.
What areas in the CNS are involved
in pain generation and perception?
 Afferent pathways,
 CNS and efferent pathways.
 Nociceptors transmit pain sensation to
the dorsal horn of the spinal cord
(substantia gelatinosa, laminae) across
to the contralateral spinal cord and
through spinothalamic tracts to the
thalamus 21/o8/20
09
8
PERIPHERAL TRANSMISSION
 Transmission occurs from the peripheral
receptor to the brain as one continuous
process, for convenience this section is divided
into peripheral and central transmission.
 Peripheral transmission of pain consists of
production of electrical signals at pain nerve
endings (transduction) followed by
propagation of those signals through the
peripheral nervous system (transmission).
Transduction
 The primary sensory structure that
accomplishes transduction is the nociceptor.
Most nociceptors are free nerve endings that
sense heat, mechanical and chemical tissue
damage. Several types are described:
 1. mechanoreceptors, which respond to
pinch and pinprick,
 2. silent nociceptors which respond only in
the presence of inflammation, and
 3. polymodal mechano-heat nociceptors.
Physiology of Pain
 Nociceptors
 Stimulus Transmission
 Termination
 Modulation
The pain experience begins with the
nociceptors.
 These are afferent nerves that respond to
noxious stimulation.
 Different nociceptors may preferentially react
to a specific kind noxious stimuli, such as
mechanical or temperature sensation.
 Different types of nociceptors may be found
in different sites: for example, the most
common cutaneous receptor is the polymodal
C fiber, which responds to pressure,
temperature and chemical stimuli, whereas
skeletal muscle contains mostly
chemoreceptors.
Cont..
 All nociceptors have an initial high threshold
to noxious stimuli, which decreases with
repeated stimuli.
 It is tempting to stop at this point and treat
pain as a simple reflex, in which the
nociceptor receives a noxious response and
transmits it to the brain. Much pain
treatment is based on this naive assumption.
 It is, in reality, a long and complicated
journey between the nociceptor and the
brain. Signals from the nociceptor are
transmitted to the spinal cord.
Cont..
 This is done mainly by two fibers: Ad fibers
and C fibers.
 Ad fibers are myelinated and provide the
initial pain response.
 C fibers are unmyelinated and probably
cause the slower response felt several
seconds after an injury.
 Most of these fibers enter the spinal cord
through the dorsal root ganglion and
terminate in the dorsal horn of the spinal
cord.
cont
 Generally they terminate ipsilaterally, but a
small number will cross to the contralateral
side.
 The clinical significance of this is not clear, but
it may explain the incomplete pain relief seen
after unilateral surgical ablation of this area.
 The dorsal horn is organized into areas, called
laminae, and certain pain fibers will
predictably go to specific laminae
Cont..
In the laminae the fibers synapse with
second order neurons, which take various
pathways to the brain.
 The best understood pathways are the
spinothalamic and spinoreticular
pathways.
 These pathways are named after their
points of origin and termination.
Modulation of the Stimulus.
Local chemicals.
 No "pain transmitter" has been identified. However,
many substances can modulate a nociceptor's response
to noxious stimuli.
 The best understood is substance P, which may work
indirectly through vasodilatory effects.
 Other chemicals that have a role in pain modulation
include prostaglandin, serotonin, histamine,
acetylcholine, bradykinin, slow-reacting substance of
anaphylaxis (SRS-A), calcitonin-gene-related peptide
(CGRP), and potassium.
Higher down-modulation.
 Virtually every part of the pain system can
reciprocally affect other parts, and the
system should be envisioned as bidirectional.
The cortex, in particular, can influence all
previous stages of pain transmission through
a variety of means.
 The most obvious is through attentional
processes. Most of us are familiar with
stories of combat victims who performed
heroic acts after injury, apparently unaware
of their pain until hours later.
Cont..
 More common are reports from chronic pain
patients that their pain seems to get worse
at night, presumably when there is less
distraction.
 The meaning of pain can also influence its
perception--for example, pain perceived as
jeopardizing health (e.g.. cancer pain) can
seem worse than pain that is not life
threatening.
 Finally, a variety of learned phenomena,
such as cultural factors, can affect one's
perception and expression of pain.
Physiology of Pain
 Multiple
 Redundant
 Reciprocal
 Complex
Assessment of Pain
Immediate Pain, Physical Functioning, Psychological Factors Pain
Behaviors, Objective Correlates and Pain is always subjective.
 It is the result of a variety of factors.
 The assessment of pain, therefore, must rely on methods that are
necessarily subjective and multidimensional.
 Currently there is no universal "gold standard" for pain assessment,
and it is not the purpose here to outline a blueprint for such an
assessment.
 However, any approach must acknowledge the many different
dimensions of the pain experience.
 These dimensions are discussed in the following slides and include
the areas bulleted above.
Cont..
 Thus, the take home is that pain is very
complex.
 It is not like other senses. There are
multiple systems involved, and they are
reciprocally influenced by what appears
to be a central control over the
process.
Assessment: Immediate Pain
 Intensity
 Location
 Affective Response
 Composite Measures
Intensity.
 Most commonly, we wish to quantify the intensity of the pain.
 We might give the patient a list of adjectives to describe
the pain, usually listed in order of increasing intensity.
 Alternately, we might ask the patient to give a numerical
value to the pain intensity.
 In the latter case, we often ask patients to rate the pain
from one to 10, one being no pain and 10 the most pain
they can imagine.
 The latter approach is particularly practical in that it
rapid and easy to do, and most patients can readily
understand the task.
 This can help us track changes in intensity over time, for
example, in response to treatment.
Introduction
Classification of Pain
 Acute or Chronic
 Nociceptive or Neuropathic
Introduction
Pain Signal Processing:
Pain perception is a complex phenomenon
involving sophisticated transmission
pathways in the nervous system
 With many pain signal transmission points,
there exists opportunity!
Acute Pain
 Pain in Perioperative Setting
 Pain in Patients with Severe or Concurrent
Medical Illnesses (Pancreatitis)
 Acute Pain Related to Cancer or Cancer
Treatment
 Labor Pain
Acute Perioperative Pain
Pain that is Present in a
Surgical Patient Because of
Preexisting Disease, the
Surgical Procedure, or a
Combination of Both
Why Treat Pain?
 Basic human right!
 ↓ pain and suffering
 ↓ complications –
 ↓ likelihood of chronic pain development
 ↑ patient satisfaction
 ↑ speed of recovery → ↓ length of stay → ↓
cost
 ↑ productivity and quality of life
Adverse Effects of Poor Pain Control
 CVS: MI, dysrhythmias
 Resp: atelectasis, pneumonia
 GI: ileus, anastomotic failure
 Endocrine: “stress hormones”
 Hypercoagulable state: DVT, PE
 Impaired immunological state
Infection, cancer, wound healing
 Psychological:
Anxiety, Depression, Fatigue
Importance of
Pain Management
 Adequate Pain Control
 Reduce the Risk of Adverse
Outcomes
 Maintain the Patient’s Functional
Ability, as well as Psychological Well-
being
 Enhance the Quality of Life
 Shortened Hospital Stay and Reduced
Cost
Adverse Outcomes Associated with
Management ofAcute Pain
 Respiratory Depression
 Circulatory Depression
 Sedation
 Nausea and Vomiting
 Pruritus
 Urinary Retention
 Impairment of Bowel Function
Adverse Outcome of Undertreatment
of Acute Pain
Thromboembolic or Pulmonary
Complications
Needless Suffering
Development of Chronic Pain
Adverse Effects of Poor Pain Control
“… it remains a common misconception amongst
clinicians that acute postoperative pain is a
transient condition involving physiological
nociceptive stimulation, with a variable
affective component, that differs markedly in its
pathophysiological basis from chronic pain
syndromes.”
Pain Assessment
Pain History
O – Onset
P – Provoking / Palliating factors
Q – Quality / Quantity
R – Radiation
S – Severity
T – Timing
Pain Assessment
Origin of Pain
Acute Pain
ie. Incisional pain, acute appendicitis
Chronic Pain
ie. Chronic back pain
Acute on Chronic Pain
Acute and chronic causes may or
may not be related to each other
Pain Assessment Tools
 In Pediatric Patients:
Physiologic and Behavioral Indicators
of Pain ( Infants, Toddlers, Nonverbal
or Critically Ill Children)
Face Scale (Age 3-10 yrs)
Visual Analogue Scales (Age 10-18)
Pain Assessment .VAS,VPIS,0-10 NPIS &
FACES SCALE
Visual Analogue Scale
Pain Assessment
Current Pain Medications
 Accuracy and detail are very important!
 Name, dose, frequency, route
 ie. Oxycontin 10mg PO TID
 Don’t forget to re-order or factor in patient’s pre-
existing pain Rx usage when writing orders
Conflicts with HPI(Hx, of pr. Illness) PMH(past med. Hx)
 Renal disease → avoid morphine, NSAID’s
 Vomiting → avoid oral forms of medication
 Short gut/high output stomas → avoid CR
formulations
Pain Assessment
Allergies / Intolerances
 Drug allergies
 Document drug, adverse reaction and
severity
 Intolerances
 Nausea / vomiting, hallucinations,
disorientation, etc.
Very important to differentiate between an allergy and an intolerance!
Methods to Treat Pain
Pharmacologic manegement
 Alter Nerve Conduction (Local
Anesthetics)
 Modify Transmission in the Dorsal Horn
(Opioids, Antidepressants)
Routes of Administration
 PO
 PR
 IV
 IM
 Transdermal
 Transmucosal
 Epidural
 Intrathecal
Methods to Treat Pain
 Pharmacologic
 Medications (po, iv, im, sc, pr, transdermal)
 Acetaminophen
 NSAIDs
 Opioids
 Gabapentin
 NMDA antagonists
 Alpha-2 agonists
 Procedures
 Regional Anesthesia
 LA infiltration at incision site
 Surgical Intervention
 Non-Pharmacologic / Non-Surgical
WHO Analgesic Ladder
Non-Opioid Analgesics
Acetaminophen
NSAIDs (Aspirin, Ibuprofen,
Ketorolac,
COX-2 Inhibitors)
Lidocaine Patch (Lidoderm)
NSAIDs
 Relieve of Mild to Moderate Pain
 Complication:
GI Discomfort
GI Bleeding (Inhibition of COX-1)
Nephrotoxicity
Inhibition of Platelet Aggregation
Osteogenesis
Ketorolac
Potent Analgesic
Parenteral (IV or IM)
15-30 mg Q 6hr
Patients Older than 16 yrs
Should not Exceed 5 days
Multimodal Analgesia
Using more than one drug for pain control
 Different drugs with different mechanisms/sites
of action along pain pathway
 Each with a lower dose than if used alone
 Can provide additive or synergistic effects
 Provides better analgesia with less side effects
(mainly opiate related S/E)
Always consider multimodal analgesia when
treating pain
Acetaminophen
 First-line treatment if no contraindication
 Mechanism: thought to inhibit prostaglandin
synthesis in CNS → analgesia, antipyretic
 Typical dose: 650 to 1000 mg PO Q6H
 Max dose: 4 g / 24 hrs from all sources
 Warning: ↓ dose / avoid in those with liver damage
NSAIDs
 Also, first-line treatment
 Mechanism
 Block cyclooxygenase (COX) enzyme
→ ↓ prostaglandin synthesis
 COX-2 → Prostaglandins → pain,
inflammation, fever
 COX-1 → Prostaglandins → gastric
protection, hemostasis
NSAIDs
 Warnings: ↓dose / avoid if
 GI ulceration
 Bleeding disorders / Coagulopathy
 Renal dysfunction
 High cardiac risk – COXII inhibitors
 Asthma
 Allergy
 ?Avoid celecoxib if allergic to Sulpha
Concern for anastomotic leaks?
Opioid Analgesics
 Bind to Opioid Receptors:
 Mu, Delta and Kappa
 Morphine, Hydromorphone, Meperidine,
Fentanyl, Codeine, Methadone,
Oxycodone, Hydrocodone, Tramodol
 Opioids may be Combined with NSAIDs
to Enhance the Opioid Analgesic Effect
Opioids
Key Points:
 Centrally acting on opioid receptors
 No ceiling effect
 High dose/response variability in non-opiate
users
 Previous dependence creates a challenge in
acute on chronic pain management cases
 Balancing safety and efficacy can be difficult
(OSA patients)
 Side effects may limit reaching effective dose
Opioids
Side Effects
 Nausea / Vomiting
 Sedation
 Respiratory Depression
 Pruritus
 Constipation
 Urinary Retention
 Ileus
 Tolerance
Opioids
 Morphine
 Most commonly prescribed opioid in hospital
 Metabolism:
 Conjugation with glucuronic acid in liver and kidney
 Morphine-3-glucuronide (inactive)
 Morphine-6-glucuronide (active)
 Impaired morphine glucuronide elimination in renal failure
 Prolonged respiratory depression with small doses
 Due to metabolite build-up (morphine-6-glucuronide)
Opioids
 Hydromorphone (Dilaudid)
 Better tolerated by elderly, better S/E profile
 Preferred over morphine for renal disease
patients
 Low cost, IV and PO forms available
 Oxycodone
 Good S/E profile, but $$
 PO form only
 Percocet (oxycodone + acetaminophen)
Opioids
 Codeine
 1/10th Potency of morphine
 Metabolized into morphine by body
 Ineffective in 10% of Caucasian patents
 Challenge with combination formulations
 Meperidine (Demerol)
 Not very potent
 Decreases seizure threshold, dystonic reactions
 Neurotoxic metabolite (normeperidine)
 Avoid in renal disease
Opioids - Formulations
 Short acting forms
Need to be dosed frequently to maintain
consistent analgesia
 Controlled Release forms
Provides more consistent steady state level
Helpful for severe pain or chronic pain situations
Never crush / split / chew controlled release pills
Opioids
Drug PO
mg
IV
mg
Starting
Oral Dose
mg
Comments
Morphine 30 10 15-30 MS Contin, Release 8-12 hrs
MSIR for BTP
Hydro-
morphone
7.5 1.5 4-8 Duration Slightly Shorter
than Morphine
Meperidine 300 75 Duration Slightly Shorter
than Morphine
Normeperidine Causes CNS
Toxicity
Methadone 20 10 5-10 Qd Long Half-Life, 24-36 hrs
Accumulates on Days 2-3
Fentanyl 0.02-
0.05
Fentanyl Patch, 12 hrs Delay
Onset and Offset
Dose Regimens for PCA
Drug Bolus Dose
(mg)
Lock-Out
(Minutes)
Morphine 0.5-2 5-15
Hydromorphone 0.1-0.2 5-10
Fentanyl 0.01-0.02 5-10
Opioid Equianalgesic Table
Drug Equianalgesic Dose Initial Adult Dose (>50kg)
IV/SC/IM Oral IV/SC/IM Oral
Morphine 10 mg 20-30 mg 2-10 mg q4h 5-20 mg q4h
Hydromorphon
e
1.5 mg 4-7.5 mg 0.5-2 mg q4h 1-4 mg q4h
Oxycodone N/A 10-20 mg N/A 5-10 mg q4h
Opioids – PCA
Opioids – PCA
 Allows patient to reach their own
minimum effective analgesic
concentration (MEAC)
 Rapid titration (Morphine 1mg IV
every 5 min)
 Better analgesia and less side
effects than IM prn
Gabapentin
 Anti-epileptic drug, also useful in:
Neuropathic pain, Postherpetic neuralgia,
CRPS
 Blocks voltage-gated Ca channels in CNS
 Additive effect with NSAIDs
 Reduces opioid consumption by 16-67%
 Reduces opioid related side effects
 Drowsiness if dose increased too fast
Management of Side Effects
 Nausea / Vomiting
 Ondansetron (Zofran)
 Dimenhydrinate (Gravol)
 Metoclopramide (Maxeran)
 Changing medication(s) / ↓ dose
 Pruritus
 Diphenhydramine (Benadryl)
 Changing medication(s) / ↓ dose
Regional Anesthesia
Interventional
Management
Epidural Analgesia (Continuous
Lumbar or Thoracic Epidural
Catheter Placement, PCEA)
Spinal Analgesia
Peripheral Nerve Block ( Single
Shot or Continuous)
Regional Anesthesia
 Neuraxial Techniques
Spinal (subarachnoid) anesthesia
Epidural anesthesia (lumbar and
thoracic)
Anatomy of
Epidural Space
 Surrounds the Dural
Sac
 Anteriorly: Post.
Long. Ligament
 Posteriorly:
Ligamentum Flavum
 Laterally: Pedicles and
Intervertebral Foramina
Anatomy of Epidural Space
 AP Dimension of the Epidural Space is Largest
in the Lumbar Region, 5-6 mm
 In Thoracic Region the AP Dimension
Decreases but the Space is More Continuous
MIDLINE SAGITTAL VIEW OF THE LUMBAR SPINE
x
Regional Anesthesia
 Involves blockade of nerve impulses using local anesthetics (LA)
 LA bind sodium channels preventing propagation of action potentials
along nerves
 Wide variety of LA with different characteristics:
 ie. Lidocaine – fast onset, short duration of action
 ie. Bupivacaine (Marcaine) – slow onset, longer duration
Regional Anesthesia
 Peripheral Nerve Blocks
 Upper Limb: Brachial plexus
 Lower Limb: Femoral, sciatic, popliteal, ankle
 Abdomen: TAP blocks
 Thoracic: Paravertebral, intercostal blocks
 Use of Ultrasound Imaging has revolutionized peripheral
nerve blockade
 Safety?
 Accuracy / Improved Success
 Efficiency
Benefits of
Epidural Analgesia
 Superior analgesia to IV PCA in open abdominal procedures &
specifically in colorectal surgery
 Reduce incidence of paralytic ileus
 Blunt surgical stress response
 Improves dynamic pain relief
 Reduces systemic opiate requirements
 Facilitates early oral intake, mobilization and return of bowel fx
when part of fast track protocols
Epidural Analgesia
 Recommended as part of ERAS/fast track protocols for
colon/colorectal surgery
 Increased incidence of hypotension and urinary retention
 Management of postoperative hypotension?
Contraindications to
Neuraxial Blockade
 Absolute:
 Pt refusal or allergy to LA
 Uncorrected hypovolemia
 Infection at insertion site
 Raised ICP
 ? Coagulopathy
 Relative:
 Uncooperative patient
 Fixed cardiac output states
 Systemic infection/sepsis
 Unstable neurological disease
 Significant spine abnormalities or surgery
Management of
Opioid Overdose
Management of
Opioid Overdose
 For ↓LOC, somnolent patient:
 Stimulate patient
 Vitals/Monitors/Lines
 Airway
 Breathing
 Circulation
 CODE BLUE? CCRT? ICU? APS
Opioid Overdose Management
 Opioid Reversal
 Naloxone - opioid antagonist
 Reverses effects of opioid overdose (for 30-45min)
 MUST BE diluted before use:
 0.4mg ampule
 Dilute: 1mL Naloxone + 9mL Saline = 0.04 mg/mL
 Give 0.04 to 0.08 mg (1 to 2 mL) IV q3-5 minutes
 If no change after 0.2mg, consider other causes
Opioid Overdose Management
 Ddx:
 Seizure, stroke
 Hypoxia, Hypercarbia
 Hypotension
 Other medication effect
 Severe electrolyte or acid base abnormalities
 MI
 Sepsis
 …..etc.
Acute Pain Service
 Consult service for complex / specialized pain
management
 Anesthesia Staff + Advanced Practice Nurses
 Many post-op patients will be followed by APS
 If APS involved, APS must write all pain Rx
 Call for:
 Advice
 Difficult to manage cases
Summary
 Accurate pain assessment
 Make sure to continue or account for patient’s pre-hospital pain regimen
 Use Multimodal pain management
 Discharge pain management plan
 Acute Pain Service available 24 hrs/day
Summary
 Superior analgesia, ↓ side effects means:
 Improved patient satisfaction
 Better rehabilitation
 Earlier functional return
 Earlier discharge from hospital
 ↓ likelihood of chronic pain
 Reduced health care costs
Why Treat Pain?
 Basic human right!
 ↓ pain and suffering
 ↓ complications –
 ↓ likelihood of chronic pain development
 ↑ patient satisfaction
 ↑ speed of recovery → ↓ length of stay → ↓ cost
 ↑ productivity and quality of life
Adverse Effects of Poor Pain
Control
 CVS: MI, dysrhythmias
 Resp: atelectasis, pneumonia
 GI: ileus, anastomotic failure
 Endocrine: “stress hormones”
 Hypercoagulable state: DVT, PE
 Impaired immunological state
 Infection, cancer, wound healing
 Psychological:
 Anxiety, Depression, Fatigue
Importance of
Pain Management
 Adequate Pain Control
 Reduce the Risk of Adverse Outcomes
 Maintain the Patient’s Functional Ability, as well as
Psychological Well-being
 Enhance the Quality of Life
 Shortened Hospital Stay and Reduced Cost
Chronic pain management
Outline
 Definition
 Common Pain Syndromes
 Oral therapy
 Opioids
 Antidepressants
 Anticonvulsants
 Epidural Steroid injections
 Trigger Point Injections
 Non pharm: TENS unit, heat/cool
 Spinal cord stimulator
 Cancer Pain
Definition
 Chronic Pain: pain that persists beyond the usual course
of an acute disease or after a reasonable time for
healing to occur
 Often complex with patients having biologic disease that
coexists with congnitive, behavioural, and social factor
 May be nociceptive, neuropathic, or both
 Nociceptive: due to noxious stimulation of tissue that
activates nociceptors
 Neuropathic: due to prolonged injury of the nerve
fiber/neural structures
Common Pain Syndromes
 Low Back Pain
 Neuropathic Pain
 Diabetic Neuropathy
 Post-herpetic neuralgia
 Chronic Regional Pain Syndrome (CRPS)
 Type I and Type II
Low Back Pain
 One of the most common reasons people seek medical
attention
 Between T12 to sacro-coccygeal joint
 Conservative management
 60-70% patients recover in 6 weeks
 90% patients recover in 12 weeks
 After 12 weeks, recovery in uncertain
Low Back Pain
 Lumbosacral pain – localized to the back
 Radicular pain – distributed in the area of a nerve
Radicular Pain
 Signs: numbness, weakness, loss of deep tendon
reflexes in area of affected nerve root
 Acute Radicular Pain:
 usually due to a herniated nucleus pulposus (“herniated
disc”) or foraminal narrowing that causes inflammation of
the nerve root
 Chronic Radicular Pain:
 requires indepth diagnostics to find source, often with MRI
Lumbosacral Pain
 Acute: ususally due to myofascial injury
 Chronic: may arise from injury of many parts of the
vertebral unit
 i.e. sacroiliac joint, lumbar facts, intervertebral discs
 Diagnostic nerve blocks into these areas by pain specialist
with local anesthetic may help figure out cause
Neuropathic pain
 Pain following injury to the nervous system
 Two common examples
 Diabetic neuropathy
 Postherpetic neuralgia
Diabetic Neuropathy
 Occurs in advanced diabetes mellitus (both Type I and
Type II)
 Peripheral – usually first presents in the feet
 Pt having numbness, tingling, burning sensation
Postherpetic Neuralgia
 Occurs 3-6 months after acute infection of herpes zoster
(also called varicella zoster or Shingles)
 Usually in immunocompromised or elderly patients
 Pts have episodic sharp pain in a dermatomal
distribution
 Zoster infection can now be prevented by a vaccine
Complex Regional Pain
Syndrome (CRPS)
 Due to a known injury
 Pain disproportionate to original injury
 Pain often severe and burning, pt may have joint stiffness,
atrophic changes in muscle
 Accompanied by sympathetic nerve dysfunction
 Changed in vasoconstriction and vasodilation, changes in
temperature, loss of hair in the affected region
 2 Types
 CRPS I: absence of known nerve injury
 CRPS II: known nerve injury
Oral Pain Medications
 Opioids
 Antidepressants
 Anticonvulsants
Opioids
 See “Acute Pain” lecture for mechanism
 Oral Opioids include:
 Morphine sulfate
 Codeine
 Hydromorphone
 Tramadol
 Oxycodone
 Some opioids (morphine, oxycodone) come in
immediate and sustained release formulations
Opioids
 Pt develop tolerance quickly and can require escalating
doses
 May need to “rotate” opioids to have continued effect
 Manage side effects
 Constipation
 Nausea, Vomiting
Antidepressants
 Have an analgesic effect that occur at lower doses than
needed for their antidepressant action
 Often helpful for neuropathic pain
 Mechanism: blockade of presynaptic reuptake of
serotonin, norepinephrine, or both
 Older tricyclic antidepressants are more effective
analgesics than newer SSRIs (selective serotonin
reuptake inhibitors)
 Commonly use tricyclic antidepressants
 Nortryptiline
 Amitryptiline
Anticonvulsants
 Useful for neuropathic pain
 Mechanism: block voltage-gated sodium channels and
suppress spontaneous neural discharges
 Examples:
 Gabapentin
 Carbamezapine (first line for trigeminal neuralgia, which
is a distinct syndrome from post-herpetic neuralgia)
Epidural Steroid Injections
 Useful for patients with radicular back pain
 Usually a combination of local anesthetic (lidocaine 1%)
and a steroid is given
 Local Anesthetic provides rapid relief of pain
 Steroid takes a couple days to work, but will reduce
inflammation of nerve root and provide more long term
relief
 Typical Steroids: methylprednisolone or triamcinolone
 Usually done with x-ray/fluoroscopy by pain specialist
 Epidural needle is usually smaller gauge than typically
used in the OR.
Trigger Point Injection
 Indication: Myofascial pain – often in upper or lower
back
 Technique:
 Identify “trigger points”: areas of the back that are
particularly tender to palpation and reproduce the back
pain
 Mixture of lidocaine and bupivacaine
 Syringe with 25g needle injects ~2ml of local anesthetic
into trigger point
 While doing so, move the needle in many directions to
break up the muscle fibers
 The main benefit is from the needle breaking up the
contracted muscle fibers.
Non-pharmacologic
 Heat/Cool to affected area
 Transcutaneous Electrical Nerve Stimulation (TENS Unit)
– a device that provides external vibration to the painful
area
 Stimulates large afferent fibers
 Thought to be a distracting input that will reduce the
amount of pain sensed
Management contd..
Non-pharmacological
interventions
 Massage
 Diversion therapy
 Relaxation therapy
 Heat & cold
applications
 Yoga
18/08/2009
118
Non-pharmacologic
 Heat/Cool to affected area
 Transcutaneous Electrical Nerve Stimulation (TENS Unit)
– a device that provides external vibration to the painful
area
 Stimulates large afferent fibers
 Thought to be a distracting input that will reduce the
amount of pain sensed
Spinal Cord Stimulator
 A small device is surgically implanted with electrodes in
the epidural space
 Mechanism: activation of descending modulating
systems and inhibition of sympathetic outflow
 Indications:
 Spinal cord lesions, phantom limb pain, ischemic lower
extremity pain
 Still an area with much research.
Cancer Pain
 Pain is the most common presenting symptom of
undiagnosed malignancy
 May be due to cancer invasion or cancer treatment
 Infiltration into bone or nerves is especially painful
 May also have pain from chemotherapy, radiation, or surgical
treatment
 Primary focus is treatment of malignancy but may
require specific treatment of symptoms as well
Cancer Pain Treatment
 Multimodal
 Includes
 Opioids – mainstay
 Many routes of administration – pills, liquid, transdermal
patch, buccal, IV
 Tricyclic antidepressants
 Anticonvulsants
 Implantable intrathecal drug delivery
 Palliative sugery
 Nerve blocks with agents that permanently lyse the nerves
 Celiac plexus block for pancreatic cancer
hhhhhhhhhhhhhhhhh
define
pain
nociception
acute
NSAID
ADJUVANTS
OPIOIDS
chronic
Non-
pharmacologic
HeatTranscutaneous
Electrical Nerve
Stimulation (TENS Unit) pharmacologic

Mais conteúdo relacionado

Semelhante a Perioperative Pain Management by abe 2018.ppt

14. pain 08-09
14. pain 08-0914. pain 08-09
14. pain 08-09
Nasir Koko
 
Analgesics in oral surgery/rotary endodontic courses by indian dental academy
Analgesics in oral surgery/rotary endodontic courses by indian dental academyAnalgesics in oral surgery/rotary endodontic courses by indian dental academy
Analgesics in oral surgery/rotary endodontic courses by indian dental academy
Indian dental academy
 
pain-behvaioral medicine management overview.pptx
pain-behvaioral medicine management overview.pptxpain-behvaioral medicine management overview.pptx
pain-behvaioral medicine management overview.pptx
swetamohanty43
 

Semelhante a Perioperative Pain Management by abe 2018.ppt (20)

Electrotherapy, the Second Lecture (Pain Mechanisms).pdf
Electrotherapy, the Second Lecture (Pain Mechanisms).pdfElectrotherapy, the Second Lecture (Pain Mechanisms).pdf
Electrotherapy, the Second Lecture (Pain Mechanisms).pdf
 
Pain
PainPain
Pain
 
Pain management
Pain managementPain management
Pain management
 
Health Psy, Lec 21 Pain.pptx
Health Psy, Lec 21 Pain.pptxHealth Psy, Lec 21 Pain.pptx
Health Psy, Lec 21 Pain.pptx
 
pain physiology , pathology, types , assessment, management , recent advances
pain physiology , pathology, types , assessment, management , recent advances pain physiology , pathology, types , assessment, management , recent advances
pain physiology , pathology, types , assessment, management , recent advances
 
14. pain 08-09
14. pain 08-0914. pain 08-09
14. pain 08-09
 
Special Needs of the Patient. Pain
Special Needs of the Patient. PainSpecial Needs of the Patient. Pain
Special Needs of the Patient. Pain
 
Pain final
Pain finalPain final
Pain final
 
Concept Of Pain.pdf
Concept Of Pain.pdfConcept Of Pain.pdf
Concept Of Pain.pdf
 
Concept Of Pain.docx
Concept Of Pain.docxConcept Of Pain.docx
Concept Of Pain.docx
 
Pain
PainPain
Pain
 
Pain managment
Pain managmentPain managment
Pain managment
 
Analgesics in oral surgery/rotary endodontic courses by indian dental academy
Analgesics in oral surgery/rotary endodontic courses by indian dental academyAnalgesics in oral surgery/rotary endodontic courses by indian dental academy
Analgesics in oral surgery/rotary endodontic courses by indian dental academy
 
Analgesics in oral surgery
Analgesics in oral surgeryAnalgesics in oral surgery
Analgesics in oral surgery
 
Pain
PainPain
Pain
 
PAIN PHYSIOLOGY.ppt
PAIN PHYSIOLOGY.pptPAIN PHYSIOLOGY.ppt
PAIN PHYSIOLOGY.ppt
 
Assessment and management of pain
Assessment and management of painAssessment and management of pain
Assessment and management of pain
 
pain-behvaioral medicine management overview.pptx
pain-behvaioral medicine management overview.pptxpain-behvaioral medicine management overview.pptx
pain-behvaioral medicine management overview.pptx
 
pain_management.ppt
pain_management.pptpain_management.ppt
pain_management.ppt
 
Acute pain 2020
Acute pain 2020Acute pain 2020
Acute pain 2020
 

Mais de TadesseFenta1 (20)

B SEMINAR.pptx
B SEMINAR.pptxB SEMINAR.pptx
B SEMINAR.pptx
 
EZ IO.ppt
EZ IO.pptEZ IO.ppt
EZ IO.ppt
 
Pneumoperitoneum.pptx
Pneumoperitoneum.pptxPneumoperitoneum.pptx
Pneumoperitoneum.pptx
 
Physiologic changes during pregnancy.pptx
Physiologic changes during pregnancy.pptxPhysiologic changes during pregnancy.pptx
Physiologic changes during pregnancy.pptx
 
ethics abe.ppt
ethics abe.pptethics abe.ppt
ethics abe.ppt
 
Anesthetic Management of Abdominal Surgery.pptx
Anesthetic Management of Abdominal Surgery.pptxAnesthetic Management of Abdominal Surgery.pptx
Anesthetic Management of Abdominal Surgery.pptx
 
Anesthesia for Genitourinary Surgery.pptx
Anesthesia for Genitourinary Surgery.pptxAnesthesia for Genitourinary Surgery.pptx
Anesthesia for Genitourinary Surgery.pptx
 
Combitube.ppt
Combitube.pptCombitube.ppt
Combitube.ppt
 
RESPIRATORY PHYSIOLOGY.pptx
RESPIRATORY PHYSIOLOGY.pptxRESPIRATORY PHYSIOLOGY.pptx
RESPIRATORY PHYSIOLOGY.pptx
 
Regional_Anesthesia lec.ppt
Regional_Anesthesia lec.pptRegional_Anesthesia lec.ppt
Regional_Anesthesia lec.ppt
 
new thorasic 4th.pptx
new thorasic 4th.pptxnew thorasic 4th.pptx
new thorasic 4th.pptx
 
Anesthesia for Patients with Renal Disease.pptx
Anesthesia for Patients with Renal Disease.pptxAnesthesia for Patients with Renal Disease.pptx
Anesthesia for Patients with Renal Disease.pptx
 
hadout 3.ppt
hadout 3.ppthadout 3.ppt
hadout 3.ppt
 
Anaesthetic-Management-of-Burns.pptx
Anaesthetic-Management-of-Burns.pptxAnaesthetic-Management-of-Burns.pptx
Anaesthetic-Management-of-Burns.pptx
 
Airway equipment.pptx
Airway equipment.pptxAirway equipment.pptx
Airway equipment.pptx
 
9.hazards.ppt
9.hazards.ppt9.hazards.ppt
9.hazards.ppt
 
3._ Instrument Processing.ppt
3._ Instrument Processing.ppt3._ Instrument Processing.ppt
3._ Instrument Processing.ppt
 
2.ORT for anesthetics - Ip and hh.pptx
2.ORT for anesthetics - Ip and hh.pptx2.ORT for anesthetics - Ip and hh.pptx
2.ORT for anesthetics - Ip and hh.pptx
 
1.introdaction OR.ppt
1.introdaction OR.ppt1.introdaction OR.ppt
1.introdaction OR.ppt
 
fluid.pptx
fluid.pptxfluid.pptx
fluid.pptx
 

Último

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Último (20)

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 

Perioperative Pain Management by abe 2018.ppt

  • 1. Acute and chronic pain Management k/Mariam Tamrat
  • 2. Pain lecture  Module Title: Anaesthesia Management III  Course Title:- ICU and Pain Management  Course Number:- Anst 5172  Credit Hours:- 3  Course Description:- This course is designed to enable the anaesthetist to effectively assess and manage pain as well as identify, assess and manage patients who are critically ill. 21/08/09 2
  • 3. Cont..  Course Objectives:-  By the end of the course the student will be able to:  Define pain & explain the physiology of pain  Competently assess & manage acute post operative and non post-operative pain.  Understand the basics of chronic pain management 21/10/20 09 3
  • 4. Pain… What is the real definition of pain? And what is pain management?? How can this information help me??? 18/8/09 4
  • 5. Group Assignment  G1. Describe the characteristics and genesis of pain  G2. Explain the categories of pain  G3.Manage pain Effectively  G4.Consequences of untreated pain Submit after a week.
  • 6. Definition of Pain An Unpleasant Sensory and Emotional Experience Associated with Actual or Potential Tissue Damage, or Described in Terms of Such Damage.
  • 7. Physiology of Pain INTRODUCTION  Pain is defined by the International Association for the Study of Pain (IASP) as ‘an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage’.  Pain has objective, physiological sensory aspects as well as subjective, emotional and psychological components.  The term ‘nociception’ is used only to describe the neural response to traumatic or noxious stimuli.
  • 8. What areas in the CNS are involved in pain generation and perception?  Afferent pathways,  CNS and efferent pathways.  Nociceptors transmit pain sensation to the dorsal horn of the spinal cord (substantia gelatinosa, laminae) across to the contralateral spinal cord and through spinothalamic tracts to the thalamus 21/o8/20 09 8
  • 9. PERIPHERAL TRANSMISSION  Transmission occurs from the peripheral receptor to the brain as one continuous process, for convenience this section is divided into peripheral and central transmission.  Peripheral transmission of pain consists of production of electrical signals at pain nerve endings (transduction) followed by propagation of those signals through the peripheral nervous system (transmission).
  • 10. Transduction  The primary sensory structure that accomplishes transduction is the nociceptor. Most nociceptors are free nerve endings that sense heat, mechanical and chemical tissue damage. Several types are described:  1. mechanoreceptors, which respond to pinch and pinprick,  2. silent nociceptors which respond only in the presence of inflammation, and  3. polymodal mechano-heat nociceptors.
  • 11. Physiology of Pain  Nociceptors  Stimulus Transmission  Termination  Modulation
  • 12. The pain experience begins with the nociceptors.  These are afferent nerves that respond to noxious stimulation.  Different nociceptors may preferentially react to a specific kind noxious stimuli, such as mechanical or temperature sensation.  Different types of nociceptors may be found in different sites: for example, the most common cutaneous receptor is the polymodal C fiber, which responds to pressure, temperature and chemical stimuli, whereas skeletal muscle contains mostly chemoreceptors.
  • 13. Cont..  All nociceptors have an initial high threshold to noxious stimuli, which decreases with repeated stimuli.  It is tempting to stop at this point and treat pain as a simple reflex, in which the nociceptor receives a noxious response and transmits it to the brain. Much pain treatment is based on this naive assumption.  It is, in reality, a long and complicated journey between the nociceptor and the brain. Signals from the nociceptor are transmitted to the spinal cord.
  • 14. Cont..  This is done mainly by two fibers: Ad fibers and C fibers.  Ad fibers are myelinated and provide the initial pain response.  C fibers are unmyelinated and probably cause the slower response felt several seconds after an injury.  Most of these fibers enter the spinal cord through the dorsal root ganglion and terminate in the dorsal horn of the spinal cord.
  • 15. cont  Generally they terminate ipsilaterally, but a small number will cross to the contralateral side.  The clinical significance of this is not clear, but it may explain the incomplete pain relief seen after unilateral surgical ablation of this area.  The dorsal horn is organized into areas, called laminae, and certain pain fibers will predictably go to specific laminae
  • 16. Cont.. In the laminae the fibers synapse with second order neurons, which take various pathways to the brain.  The best understood pathways are the spinothalamic and spinoreticular pathways.  These pathways are named after their points of origin and termination.
  • 17. Modulation of the Stimulus. Local chemicals.  No "pain transmitter" has been identified. However, many substances can modulate a nociceptor's response to noxious stimuli.  The best understood is substance P, which may work indirectly through vasodilatory effects.  Other chemicals that have a role in pain modulation include prostaglandin, serotonin, histamine, acetylcholine, bradykinin, slow-reacting substance of anaphylaxis (SRS-A), calcitonin-gene-related peptide (CGRP), and potassium.
  • 18. Higher down-modulation.  Virtually every part of the pain system can reciprocally affect other parts, and the system should be envisioned as bidirectional. The cortex, in particular, can influence all previous stages of pain transmission through a variety of means.  The most obvious is through attentional processes. Most of us are familiar with stories of combat victims who performed heroic acts after injury, apparently unaware of their pain until hours later.
  • 19. Cont..  More common are reports from chronic pain patients that their pain seems to get worse at night, presumably when there is less distraction.  The meaning of pain can also influence its perception--for example, pain perceived as jeopardizing health (e.g.. cancer pain) can seem worse than pain that is not life threatening.  Finally, a variety of learned phenomena, such as cultural factors, can affect one's perception and expression of pain.
  • 20. Physiology of Pain  Multiple  Redundant  Reciprocal  Complex
  • 21. Assessment of Pain Immediate Pain, Physical Functioning, Psychological Factors Pain Behaviors, Objective Correlates and Pain is always subjective.  It is the result of a variety of factors.  The assessment of pain, therefore, must rely on methods that are necessarily subjective and multidimensional.  Currently there is no universal "gold standard" for pain assessment, and it is not the purpose here to outline a blueprint for such an assessment.  However, any approach must acknowledge the many different dimensions of the pain experience.  These dimensions are discussed in the following slides and include the areas bulleted above.
  • 22. Cont..  Thus, the take home is that pain is very complex.  It is not like other senses. There are multiple systems involved, and they are reciprocally influenced by what appears to be a central control over the process.
  • 23. Assessment: Immediate Pain  Intensity  Location  Affective Response  Composite Measures
  • 24. Intensity.  Most commonly, we wish to quantify the intensity of the pain.  We might give the patient a list of adjectives to describe the pain, usually listed in order of increasing intensity.  Alternately, we might ask the patient to give a numerical value to the pain intensity.  In the latter case, we often ask patients to rate the pain from one to 10, one being no pain and 10 the most pain they can imagine.  The latter approach is particularly practical in that it rapid and easy to do, and most patients can readily understand the task.  This can help us track changes in intensity over time, for example, in response to treatment.
  • 25. Introduction Classification of Pain  Acute or Chronic  Nociceptive or Neuropathic
  • 26. Introduction Pain Signal Processing: Pain perception is a complex phenomenon involving sophisticated transmission pathways in the nervous system  With many pain signal transmission points, there exists opportunity!
  • 27. Acute Pain  Pain in Perioperative Setting  Pain in Patients with Severe or Concurrent Medical Illnesses (Pancreatitis)  Acute Pain Related to Cancer or Cancer Treatment  Labor Pain
  • 28. Acute Perioperative Pain Pain that is Present in a Surgical Patient Because of Preexisting Disease, the Surgical Procedure, or a Combination of Both
  • 29. Why Treat Pain?  Basic human right!  ↓ pain and suffering  ↓ complications –  ↓ likelihood of chronic pain development  ↑ patient satisfaction  ↑ speed of recovery → ↓ length of stay → ↓ cost  ↑ productivity and quality of life
  • 30. Adverse Effects of Poor Pain Control  CVS: MI, dysrhythmias  Resp: atelectasis, pneumonia  GI: ileus, anastomotic failure  Endocrine: “stress hormones”  Hypercoagulable state: DVT, PE  Impaired immunological state Infection, cancer, wound healing  Psychological: Anxiety, Depression, Fatigue
  • 31. Importance of Pain Management  Adequate Pain Control  Reduce the Risk of Adverse Outcomes  Maintain the Patient’s Functional Ability, as well as Psychological Well- being  Enhance the Quality of Life  Shortened Hospital Stay and Reduced Cost
  • 32. Adverse Outcomes Associated with Management ofAcute Pain  Respiratory Depression  Circulatory Depression  Sedation  Nausea and Vomiting  Pruritus  Urinary Retention  Impairment of Bowel Function
  • 33. Adverse Outcome of Undertreatment of Acute Pain Thromboembolic or Pulmonary Complications Needless Suffering Development of Chronic Pain
  • 34. Adverse Effects of Poor Pain Control “… it remains a common misconception amongst clinicians that acute postoperative pain is a transient condition involving physiological nociceptive stimulation, with a variable affective component, that differs markedly in its pathophysiological basis from chronic pain syndromes.”
  • 35. Pain Assessment Pain History O – Onset P – Provoking / Palliating factors Q – Quality / Quantity R – Radiation S – Severity T – Timing
  • 36. Pain Assessment Origin of Pain Acute Pain ie. Incisional pain, acute appendicitis Chronic Pain ie. Chronic back pain Acute on Chronic Pain Acute and chronic causes may or may not be related to each other
  • 37. Pain Assessment Tools  In Pediatric Patients: Physiologic and Behavioral Indicators of Pain ( Infants, Toddlers, Nonverbal or Critically Ill Children) Face Scale (Age 3-10 yrs) Visual Analogue Scales (Age 10-18)
  • 38. Pain Assessment .VAS,VPIS,0-10 NPIS & FACES SCALE Visual Analogue Scale
  • 39.
  • 40.
  • 41. Pain Assessment Current Pain Medications  Accuracy and detail are very important!  Name, dose, frequency, route  ie. Oxycontin 10mg PO TID  Don’t forget to re-order or factor in patient’s pre- existing pain Rx usage when writing orders Conflicts with HPI(Hx, of pr. Illness) PMH(past med. Hx)  Renal disease → avoid morphine, NSAID’s  Vomiting → avoid oral forms of medication  Short gut/high output stomas → avoid CR formulations
  • 42. Pain Assessment Allergies / Intolerances  Drug allergies  Document drug, adverse reaction and severity  Intolerances  Nausea / vomiting, hallucinations, disorientation, etc. Very important to differentiate between an allergy and an intolerance!
  • 43. Methods to Treat Pain Pharmacologic manegement  Alter Nerve Conduction (Local Anesthetics)  Modify Transmission in the Dorsal Horn (Opioids, Antidepressants)
  • 44. Routes of Administration  PO  PR  IV  IM  Transdermal  Transmucosal  Epidural  Intrathecal
  • 45. Methods to Treat Pain  Pharmacologic  Medications (po, iv, im, sc, pr, transdermal)  Acetaminophen  NSAIDs  Opioids  Gabapentin  NMDA antagonists  Alpha-2 agonists  Procedures  Regional Anesthesia  LA infiltration at incision site  Surgical Intervention  Non-Pharmacologic / Non-Surgical
  • 47. Non-Opioid Analgesics Acetaminophen NSAIDs (Aspirin, Ibuprofen, Ketorolac, COX-2 Inhibitors) Lidocaine Patch (Lidoderm)
  • 48. NSAIDs  Relieve of Mild to Moderate Pain  Complication: GI Discomfort GI Bleeding (Inhibition of COX-1) Nephrotoxicity Inhibition of Platelet Aggregation Osteogenesis
  • 49. Ketorolac Potent Analgesic Parenteral (IV or IM) 15-30 mg Q 6hr Patients Older than 16 yrs Should not Exceed 5 days
  • 50.
  • 51. Multimodal Analgesia Using more than one drug for pain control  Different drugs with different mechanisms/sites of action along pain pathway  Each with a lower dose than if used alone  Can provide additive or synergistic effects  Provides better analgesia with less side effects (mainly opiate related S/E) Always consider multimodal analgesia when treating pain
  • 52. Acetaminophen  First-line treatment if no contraindication  Mechanism: thought to inhibit prostaglandin synthesis in CNS → analgesia, antipyretic  Typical dose: 650 to 1000 mg PO Q6H  Max dose: 4 g / 24 hrs from all sources  Warning: ↓ dose / avoid in those with liver damage
  • 53. NSAIDs  Also, first-line treatment  Mechanism  Block cyclooxygenase (COX) enzyme → ↓ prostaglandin synthesis  COX-2 → Prostaglandins → pain, inflammation, fever  COX-1 → Prostaglandins → gastric protection, hemostasis
  • 54. NSAIDs  Warnings: ↓dose / avoid if  GI ulceration  Bleeding disorders / Coagulopathy  Renal dysfunction  High cardiac risk – COXII inhibitors  Asthma  Allergy  ?Avoid celecoxib if allergic to Sulpha Concern for anastomotic leaks?
  • 55. Opioid Analgesics  Bind to Opioid Receptors:  Mu, Delta and Kappa  Morphine, Hydromorphone, Meperidine, Fentanyl, Codeine, Methadone, Oxycodone, Hydrocodone, Tramodol  Opioids may be Combined with NSAIDs to Enhance the Opioid Analgesic Effect
  • 56. Opioids Key Points:  Centrally acting on opioid receptors  No ceiling effect  High dose/response variability in non-opiate users  Previous dependence creates a challenge in acute on chronic pain management cases  Balancing safety and efficacy can be difficult (OSA patients)  Side effects may limit reaching effective dose
  • 57. Opioids Side Effects  Nausea / Vomiting  Sedation  Respiratory Depression  Pruritus  Constipation  Urinary Retention  Ileus  Tolerance
  • 58. Opioids  Morphine  Most commonly prescribed opioid in hospital  Metabolism:  Conjugation with glucuronic acid in liver and kidney  Morphine-3-glucuronide (inactive)  Morphine-6-glucuronide (active)  Impaired morphine glucuronide elimination in renal failure  Prolonged respiratory depression with small doses  Due to metabolite build-up (morphine-6-glucuronide)
  • 59. Opioids  Hydromorphone (Dilaudid)  Better tolerated by elderly, better S/E profile  Preferred over morphine for renal disease patients  Low cost, IV and PO forms available  Oxycodone  Good S/E profile, but $$  PO form only  Percocet (oxycodone + acetaminophen)
  • 60. Opioids  Codeine  1/10th Potency of morphine  Metabolized into morphine by body  Ineffective in 10% of Caucasian patents  Challenge with combination formulations  Meperidine (Demerol)  Not very potent  Decreases seizure threshold, dystonic reactions  Neurotoxic metabolite (normeperidine)  Avoid in renal disease
  • 61. Opioids - Formulations  Short acting forms Need to be dosed frequently to maintain consistent analgesia  Controlled Release forms Provides more consistent steady state level Helpful for severe pain or chronic pain situations Never crush / split / chew controlled release pills
  • 62. Opioids Drug PO mg IV mg Starting Oral Dose mg Comments Morphine 30 10 15-30 MS Contin, Release 8-12 hrs MSIR for BTP Hydro- morphone 7.5 1.5 4-8 Duration Slightly Shorter than Morphine Meperidine 300 75 Duration Slightly Shorter than Morphine Normeperidine Causes CNS Toxicity Methadone 20 10 5-10 Qd Long Half-Life, 24-36 hrs Accumulates on Days 2-3 Fentanyl 0.02- 0.05 Fentanyl Patch, 12 hrs Delay Onset and Offset
  • 63. Dose Regimens for PCA Drug Bolus Dose (mg) Lock-Out (Minutes) Morphine 0.5-2 5-15 Hydromorphone 0.1-0.2 5-10 Fentanyl 0.01-0.02 5-10
  • 64. Opioid Equianalgesic Table Drug Equianalgesic Dose Initial Adult Dose (>50kg) IV/SC/IM Oral IV/SC/IM Oral Morphine 10 mg 20-30 mg 2-10 mg q4h 5-20 mg q4h Hydromorphon e 1.5 mg 4-7.5 mg 0.5-2 mg q4h 1-4 mg q4h Oxycodone N/A 10-20 mg N/A 5-10 mg q4h
  • 66. Opioids – PCA  Allows patient to reach their own minimum effective analgesic concentration (MEAC)  Rapid titration (Morphine 1mg IV every 5 min)  Better analgesia and less side effects than IM prn
  • 67. Gabapentin  Anti-epileptic drug, also useful in: Neuropathic pain, Postherpetic neuralgia, CRPS  Blocks voltage-gated Ca channels in CNS  Additive effect with NSAIDs  Reduces opioid consumption by 16-67%  Reduces opioid related side effects  Drowsiness if dose increased too fast
  • 68. Management of Side Effects  Nausea / Vomiting  Ondansetron (Zofran)  Dimenhydrinate (Gravol)  Metoclopramide (Maxeran)  Changing medication(s) / ↓ dose  Pruritus  Diphenhydramine (Benadryl)  Changing medication(s) / ↓ dose
  • 70. Interventional Management Epidural Analgesia (Continuous Lumbar or Thoracic Epidural Catheter Placement, PCEA) Spinal Analgesia Peripheral Nerve Block ( Single Shot or Continuous)
  • 71. Regional Anesthesia  Neuraxial Techniques Spinal (subarachnoid) anesthesia Epidural anesthesia (lumbar and thoracic)
  • 72. Anatomy of Epidural Space  Surrounds the Dural Sac  Anteriorly: Post. Long. Ligament  Posteriorly: Ligamentum Flavum  Laterally: Pedicles and Intervertebral Foramina
  • 73. Anatomy of Epidural Space  AP Dimension of the Epidural Space is Largest in the Lumbar Region, 5-6 mm  In Thoracic Region the AP Dimension Decreases but the Space is More Continuous
  • 74. MIDLINE SAGITTAL VIEW OF THE LUMBAR SPINE
  • 75. x
  • 76.
  • 77.
  • 78.
  • 79.
  • 80. Regional Anesthesia  Involves blockade of nerve impulses using local anesthetics (LA)  LA bind sodium channels preventing propagation of action potentials along nerves  Wide variety of LA with different characteristics:  ie. Lidocaine – fast onset, short duration of action  ie. Bupivacaine (Marcaine) – slow onset, longer duration
  • 81. Regional Anesthesia  Peripheral Nerve Blocks  Upper Limb: Brachial plexus  Lower Limb: Femoral, sciatic, popliteal, ankle  Abdomen: TAP blocks  Thoracic: Paravertebral, intercostal blocks  Use of Ultrasound Imaging has revolutionized peripheral nerve blockade  Safety?  Accuracy / Improved Success  Efficiency
  • 82. Benefits of Epidural Analgesia  Superior analgesia to IV PCA in open abdominal procedures & specifically in colorectal surgery  Reduce incidence of paralytic ileus  Blunt surgical stress response  Improves dynamic pain relief  Reduces systemic opiate requirements  Facilitates early oral intake, mobilization and return of bowel fx when part of fast track protocols
  • 83. Epidural Analgesia  Recommended as part of ERAS/fast track protocols for colon/colorectal surgery  Increased incidence of hypotension and urinary retention  Management of postoperative hypotension?
  • 84. Contraindications to Neuraxial Blockade  Absolute:  Pt refusal or allergy to LA  Uncorrected hypovolemia  Infection at insertion site  Raised ICP  ? Coagulopathy  Relative:  Uncooperative patient  Fixed cardiac output states  Systemic infection/sepsis  Unstable neurological disease  Significant spine abnormalities or surgery
  • 86. Management of Opioid Overdose  For ↓LOC, somnolent patient:  Stimulate patient  Vitals/Monitors/Lines  Airway  Breathing  Circulation  CODE BLUE? CCRT? ICU? APS
  • 87. Opioid Overdose Management  Opioid Reversal  Naloxone - opioid antagonist  Reverses effects of opioid overdose (for 30-45min)  MUST BE diluted before use:  0.4mg ampule  Dilute: 1mL Naloxone + 9mL Saline = 0.04 mg/mL  Give 0.04 to 0.08 mg (1 to 2 mL) IV q3-5 minutes  If no change after 0.2mg, consider other causes
  • 88. Opioid Overdose Management  Ddx:  Seizure, stroke  Hypoxia, Hypercarbia  Hypotension  Other medication effect  Severe electrolyte or acid base abnormalities  MI  Sepsis  …..etc.
  • 89. Acute Pain Service  Consult service for complex / specialized pain management  Anesthesia Staff + Advanced Practice Nurses  Many post-op patients will be followed by APS  If APS involved, APS must write all pain Rx  Call for:  Advice  Difficult to manage cases
  • 90. Summary  Accurate pain assessment  Make sure to continue or account for patient’s pre-hospital pain regimen  Use Multimodal pain management  Discharge pain management plan  Acute Pain Service available 24 hrs/day
  • 91. Summary  Superior analgesia, ↓ side effects means:  Improved patient satisfaction  Better rehabilitation  Earlier functional return  Earlier discharge from hospital  ↓ likelihood of chronic pain  Reduced health care costs
  • 92. Why Treat Pain?  Basic human right!  ↓ pain and suffering  ↓ complications –  ↓ likelihood of chronic pain development  ↑ patient satisfaction  ↑ speed of recovery → ↓ length of stay → ↓ cost  ↑ productivity and quality of life
  • 93. Adverse Effects of Poor Pain Control  CVS: MI, dysrhythmias  Resp: atelectasis, pneumonia  GI: ileus, anastomotic failure  Endocrine: “stress hormones”  Hypercoagulable state: DVT, PE  Impaired immunological state  Infection, cancer, wound healing  Psychological:  Anxiety, Depression, Fatigue
  • 94. Importance of Pain Management  Adequate Pain Control  Reduce the Risk of Adverse Outcomes  Maintain the Patient’s Functional Ability, as well as Psychological Well-being  Enhance the Quality of Life  Shortened Hospital Stay and Reduced Cost
  • 96. Outline  Definition  Common Pain Syndromes  Oral therapy  Opioids  Antidepressants  Anticonvulsants  Epidural Steroid injections  Trigger Point Injections  Non pharm: TENS unit, heat/cool  Spinal cord stimulator  Cancer Pain
  • 97. Definition  Chronic Pain: pain that persists beyond the usual course of an acute disease or after a reasonable time for healing to occur  Often complex with patients having biologic disease that coexists with congnitive, behavioural, and social factor  May be nociceptive, neuropathic, or both  Nociceptive: due to noxious stimulation of tissue that activates nociceptors  Neuropathic: due to prolonged injury of the nerve fiber/neural structures
  • 98. Common Pain Syndromes  Low Back Pain  Neuropathic Pain  Diabetic Neuropathy  Post-herpetic neuralgia  Chronic Regional Pain Syndrome (CRPS)  Type I and Type II
  • 99. Low Back Pain  One of the most common reasons people seek medical attention  Between T12 to sacro-coccygeal joint  Conservative management  60-70% patients recover in 6 weeks  90% patients recover in 12 weeks  After 12 weeks, recovery in uncertain
  • 100. Low Back Pain  Lumbosacral pain – localized to the back  Radicular pain – distributed in the area of a nerve
  • 101.
  • 102. Radicular Pain  Signs: numbness, weakness, loss of deep tendon reflexes in area of affected nerve root  Acute Radicular Pain:  usually due to a herniated nucleus pulposus (“herniated disc”) or foraminal narrowing that causes inflammation of the nerve root  Chronic Radicular Pain:  requires indepth diagnostics to find source, often with MRI
  • 103. Lumbosacral Pain  Acute: ususally due to myofascial injury  Chronic: may arise from injury of many parts of the vertebral unit  i.e. sacroiliac joint, lumbar facts, intervertebral discs  Diagnostic nerve blocks into these areas by pain specialist with local anesthetic may help figure out cause
  • 104.
  • 105.
  • 106. Neuropathic pain  Pain following injury to the nervous system  Two common examples  Diabetic neuropathy  Postherpetic neuralgia
  • 107. Diabetic Neuropathy  Occurs in advanced diabetes mellitus (both Type I and Type II)  Peripheral – usually first presents in the feet  Pt having numbness, tingling, burning sensation
  • 108. Postherpetic Neuralgia  Occurs 3-6 months after acute infection of herpes zoster (also called varicella zoster or Shingles)  Usually in immunocompromised or elderly patients  Pts have episodic sharp pain in a dermatomal distribution  Zoster infection can now be prevented by a vaccine
  • 109. Complex Regional Pain Syndrome (CRPS)  Due to a known injury  Pain disproportionate to original injury  Pain often severe and burning, pt may have joint stiffness, atrophic changes in muscle  Accompanied by sympathetic nerve dysfunction  Changed in vasoconstriction and vasodilation, changes in temperature, loss of hair in the affected region  2 Types  CRPS I: absence of known nerve injury  CRPS II: known nerve injury
  • 110. Oral Pain Medications  Opioids  Antidepressants  Anticonvulsants
  • 111. Opioids  See “Acute Pain” lecture for mechanism  Oral Opioids include:  Morphine sulfate  Codeine  Hydromorphone  Tramadol  Oxycodone  Some opioids (morphine, oxycodone) come in immediate and sustained release formulations
  • 112. Opioids  Pt develop tolerance quickly and can require escalating doses  May need to “rotate” opioids to have continued effect  Manage side effects  Constipation  Nausea, Vomiting
  • 113. Antidepressants  Have an analgesic effect that occur at lower doses than needed for their antidepressant action  Often helpful for neuropathic pain  Mechanism: blockade of presynaptic reuptake of serotonin, norepinephrine, or both  Older tricyclic antidepressants are more effective analgesics than newer SSRIs (selective serotonin reuptake inhibitors)  Commonly use tricyclic antidepressants  Nortryptiline  Amitryptiline
  • 114. Anticonvulsants  Useful for neuropathic pain  Mechanism: block voltage-gated sodium channels and suppress spontaneous neural discharges  Examples:  Gabapentin  Carbamezapine (first line for trigeminal neuralgia, which is a distinct syndrome from post-herpetic neuralgia)
  • 115. Epidural Steroid Injections  Useful for patients with radicular back pain  Usually a combination of local anesthetic (lidocaine 1%) and a steroid is given  Local Anesthetic provides rapid relief of pain  Steroid takes a couple days to work, but will reduce inflammation of nerve root and provide more long term relief  Typical Steroids: methylprednisolone or triamcinolone  Usually done with x-ray/fluoroscopy by pain specialist  Epidural needle is usually smaller gauge than typically used in the OR.
  • 116. Trigger Point Injection  Indication: Myofascial pain – often in upper or lower back  Technique:  Identify “trigger points”: areas of the back that are particularly tender to palpation and reproduce the back pain  Mixture of lidocaine and bupivacaine  Syringe with 25g needle injects ~2ml of local anesthetic into trigger point  While doing so, move the needle in many directions to break up the muscle fibers  The main benefit is from the needle breaking up the contracted muscle fibers.
  • 117. Non-pharmacologic  Heat/Cool to affected area  Transcutaneous Electrical Nerve Stimulation (TENS Unit) – a device that provides external vibration to the painful area  Stimulates large afferent fibers  Thought to be a distracting input that will reduce the amount of pain sensed
  • 118. Management contd.. Non-pharmacological interventions  Massage  Diversion therapy  Relaxation therapy  Heat & cold applications  Yoga 18/08/2009 118
  • 119. Non-pharmacologic  Heat/Cool to affected area  Transcutaneous Electrical Nerve Stimulation (TENS Unit) – a device that provides external vibration to the painful area  Stimulates large afferent fibers  Thought to be a distracting input that will reduce the amount of pain sensed
  • 120. Spinal Cord Stimulator  A small device is surgically implanted with electrodes in the epidural space  Mechanism: activation of descending modulating systems and inhibition of sympathetic outflow  Indications:  Spinal cord lesions, phantom limb pain, ischemic lower extremity pain  Still an area with much research.
  • 121. Cancer Pain  Pain is the most common presenting symptom of undiagnosed malignancy  May be due to cancer invasion or cancer treatment  Infiltration into bone or nerves is especially painful  May also have pain from chemotherapy, radiation, or surgical treatment  Primary focus is treatment of malignancy but may require specific treatment of symptoms as well
  • 122. Cancer Pain Treatment  Multimodal  Includes  Opioids – mainstay  Many routes of administration – pills, liquid, transdermal patch, buccal, IV  Tricyclic antidepressants  Anticonvulsants  Implantable intrathecal drug delivery  Palliative sugery  Nerve blocks with agents that permanently lyse the nerves  Celiac plexus block for pancreatic cancer